PL1905426T3 - Kompozycja farmaceutyczna przeciw-kwasowa w postaci proszku, preparat farmaceutyczny zawierający ją, oraz sposób jej wytwarzania - Google Patents

Kompozycja farmaceutyczna przeciw-kwasowa w postaci proszku, preparat farmaceutyczny zawierający ją, oraz sposób jej wytwarzania

Info

Publication number
PL1905426T3
PL1905426T3 PL07380159T PL07380159T PL1905426T3 PL 1905426 T3 PL1905426 T3 PL 1905426T3 PL 07380159 T PL07380159 T PL 07380159T PL 07380159 T PL07380159 T PL 07380159T PL 1905426 T3 PL1905426 T3 PL 1905426T3
Authority
PL
Poland
Prior art keywords
making
powder form
preparation containing
pharmaceutical composition
acid
Prior art date
Application number
PL07380159T
Other languages
English (en)
Inventor
Los Mario Atilio
Original Assignee
Laboratorios Bago S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Bago S A filed Critical Laboratorios Bago S A
Publication of PL1905426T3 publication Critical patent/PL1905426T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL07380159T 2006-06-05 2007-06-01 Kompozycja farmaceutyczna przeciw-kwasowa w postaci proszku, preparat farmaceutyczny zawierający ją, oraz sposób jej wytwarzania PL1905426T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ARP060102333A AR056062A1 (es) 2006-06-05 2006-06-05 Composicion farmaceutica antiacida en forma de polvo, preparacion farmaceutica que la comprende y proceso para su preparacion
EP07380159A EP1905426B1 (en) 2006-06-05 2007-06-01 Anti-acid pharmaceutical composition in powder form; pharmaceutical preparation containing it and process for making it

Publications (1)

Publication Number Publication Date
PL1905426T3 true PL1905426T3 (pl) 2013-02-28

Family

ID=38572778

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07380159T PL1905426T3 (pl) 2006-06-05 2007-06-01 Kompozycja farmaceutyczna przeciw-kwasowa w postaci proszku, preparat farmaceutyczny zawierający ją, oraz sposób jej wytwarzania

Country Status (11)

Country Link
US (2) US7968118B2 (pl)
EP (1) EP1905426B1 (pl)
AR (1) AR056062A1 (pl)
BR (1) BRPI0704028B8 (pl)
DE (1) DE07380159T1 (pl)
ES (1) ES2301455T3 (pl)
MX (1) MX2007006722A (pl)
PL (1) PL1905426T3 (pl)
RU (1) RU2351332C2 (pl)
UA (1) UA95224C2 (pl)
UY (1) UY30382A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008019339A1 (de) * 2008-04-16 2009-10-22 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die medizinische Anwendung, insbesondere Antazidum
JP2013525313A (ja) 2010-04-23 2013-06-20 エス−バイオテック ホールディング エーピーエス 胃酸を中和する固形医薬組成物
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
TR201723199A2 (tr) * 2017-12-30 2019-07-22 Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi Yeni farmasötik bileşimler.
TW202126301A (zh) * 2019-10-04 2021-07-16 愛爾蘭商席歐拉斯製藥有限公司 小兒懸浮調配物
FR3107183B1 (fr) * 2020-02-19 2022-04-29 Amsellem Jean Paul Composition pour le traitement des vertiges
CN114288243B (zh) * 2022-01-24 2023-02-07 中国药科大学 一种口服抗酸原位凝胶及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4744986A (en) * 1986-03-07 1988-05-17 Rorer Pharmaceutical Corporation Process for the preparation of a viscosity-stable antacid composition
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
SE9600071D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
JP2001509791A (ja) * 1996-11-27 2001-07-24 ザ、プロクター、エンド、ギャンブル、カンパニー 胃腸障害の治療用組成物及び方法
BR0300882A (pt) * 2003-04-09 2005-05-10 Cmax Otimizacao De Resultados Composições farmacêuticas, método e uso de formulação para tratamento e prevenção de infecções associadas com helicobacter pylori em mamìferos e no ser humano
AR045061A1 (es) * 2003-07-18 2005-10-12 Santarus Inc Formulacion farmaceutica y metodo para tratar trastornos gastrointestinales causados por acido
EP1667681A4 (en) * 2003-10-03 2009-09-30 Astron Res Pvt Ltd NEW TRANSMUCOSAL ADMINISTRATION SYSTEM

Also Published As

Publication number Publication date
DE07380159T1 (de) 2008-08-21
BRPI0704028A (pt) 2008-04-01
BRPI0704028B1 (pt) 2021-02-09
MX2007006722A (es) 2009-02-18
UY30382A1 (es) 2007-07-31
RU2351332C2 (ru) 2009-04-10
ES2301455T3 (es) 2013-01-23
US20070281015A1 (en) 2007-12-06
UA95224C2 (ru) 2011-07-25
US8093271B2 (en) 2012-01-10
EP1905426A3 (en) 2008-05-21
RU2007120753A (ru) 2008-12-10
US20100160382A1 (en) 2010-06-24
US7968118B2 (en) 2011-06-28
ES2301455T1 (es) 2008-07-01
EP1905426B1 (en) 2012-09-05
EP1905426A2 (en) 2008-04-02
AR056062A1 (es) 2007-09-19
BRPI0704028B8 (pt) 2022-05-10

Similar Documents

Publication Publication Date Title
EP2010127A4 (en) FILLER COMPOSITION AND METHOD FOR ITS MANUFACTURE AND USE
PT1902706T (pt) Composições farmacêuticas estáveis de tetraciclinas em solução, seu método de obtenção e suas utilizações
PL1905426T3 (pl) Kompozycja farmaceutyczna przeciw-kwasowa w postaci proszku, preparat farmaceutyczny zawierający ją, oraz sposób jej wytwarzania
IL194546A0 (en) Arylaminopyridine derivatives and pharmaceutical compositions containing them
IL182375A0 (en) Pharmaceutical compositions comprising levetiracetam and process for their preparation
EP2057987A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING AN ENCAPSULATED STATINE NANOPARTICLE
IL178544A (en) Crystalline form - δ of ivabradine hydrochloride, process for preparation and pharmaceutical preparations containing it
GB0521708D0 (en) Method of preparing a pharmaceutical composition and pharmaceutical compositions obtainable thereby
EP2236130A4 (en) PH-SENSITIVE SOLID PHARMACEUTICAL COMPOSITION FOR ORAL FORMULATION AND MANUFACTURING METHOD THEREFOR
PL2036892T3 (pl) Pochodne 1,2,4,5-tetrahydro-3H-benzazepin, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne
ZA200907450B (en) Stabilised pharmaceutical composition containing pregabaline
IL192826A0 (en) Thiazole derivatives, their preparation and pharmaceutical compositions containing them
IL195039A0 (en) Pharmaceutical compositions containing oridonin
HUP0600293A3 (en) Zinc salt of rosuvastatine, process for its preparation and pharmaceutical compositions containing it
IL207183A (en) Dihydroindolone compounds, a process for their preparation and their pharmaceutical compositions
EP2489348A4 (en) PHARMACEUTICAL COMPOSITION WITH MEDICATION-CONTAINING FINE PARTICLES AND MANUFACTURING METHOD THEREFOR
SI1707564T1 (sl) Indanil-piperazinski derivati, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo
EP2051721A4 (en) PREPARATION AND PHARMACEUTICAL USE OF COMPOSITION FROM THE EXTRACT OF EUTERPE OLERACEA (ACAI)
GB0605676D0 (en) Improvements in extraction of powder formulations
IL213105A (en) Compounds, their preparation process, pharmaceutical preparations containing them and their use in the preparation of drugs
HK1126190A1 (en) Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them
IL203433A (en) Process for Preparing Pharmaceutical and Solid Release Controlled Compositions Containing Oxacarbazapine
IL198634A0 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
GB0716907D0 (en) Pharmaceutical powder compositions
IL189177A0 (en) Process for producing carcosporamide and pharmaceutical compositions containing cercosporamide